Trade Smarter With Equivalent Positions How can two

New Post Public Reply Private Reply Replies (0) Message Board
NITE

Trade Smarter With Equivalent Positions
How can two trades have the same risk and reward when they look so very different?

That's the frequent response when investors first learn that every option position is equivalent to a different option position. For clarification, "equivalent" refers to the fact that the positions will earn/lose the same amount at any price (when expiration arrives) for the underlying stock. It does not mean the positions are "identical."

Of all the ideas that a rookie options trader encounters, the idea of equivalence is a real eye-opener. Those who grasp the significance of this concept have an increased chance of succeeding as a trader. (For a background reading, see our Options Basics Tutorial.)

Different but Equal
Let's begin with an example, and then we'll discuss why equivalent positions exist and how you can use them to your advantage. And it is an advantage. Sometimes you discover that there's an extra $5 or $10 to be earned by making the equivalent trade . At other times, the equivalent saves money on commissions.
There are two commonly used trading strategies that are equivalent to each other. But you would never know it by the way stock brokers handle these positions. I'm referring to writing covered calls and selling naked puts. (For more, readUnderstanding Option Pricing.)

These two positions are equivalent:
1. Buy 300 shares of QZZ
Sell 3 QZZ Aug 40 calls
2. Sell 3 QZZ Aug 40 puts
What happens when expiration arrives for each of these positions?

Buying the Covered Call:
• If QZZ is above 40, the call owner exercises the options, your shares are sold at $40 per share, and you have no remaining position.
•
If QZZ is below 40, the options expire worthless and you own 300 shares
Selling the Naked Puts:
• If QZZ is above 40, the puts expire worthless and you have no remaining position.
•
If QZZ is below 40, the put owner exercises the options and you are obligated to purchase 300 shares at $40 per share. You own 300 shares.
Trade Conclusion
After expiration, your position is identical. For those who are concerned with details (and option traders must be concerned) the question arises as to what happens when the stock's final trade at expiration is 40. The answer is that you have two choices:
1. Do Nothing
You can do nothing and wait to see whether the option owner allows the calls to expire worthless or decides to exercise. This places the decision in the hands of someone else.
2. Repurchase the Options
Before the market closes for trading on expiration Friday, you can repurchase the options you sold. Once you do that, you can no longer be assigned an exercise notice. The goal is to buy those options for as little as possible, and I suggest bidding 5 cents for those options. You may want to be more aggressive and raise the bid to 10 cents, but that should not be necessary if the stock is truly trading at the strike price as the closing bell rings.

If you do buy back the options sold earlier, you may write new options expiring in a later month. This is a common practice, but it's a separate trade decision.
The positions are equivalent after expiration. But does that show that the profit/loss is always equivalent? No, it doesn't. But the truth is that options are almost always efficiently priced. When priced inefficiently, professional arbitrageurs arrive on the scene and trade to take the "free money" offered. This is not a trading idea for you. Instead, it's a reassurance that you will not find options mispriced too often. The available profit from these arbitrage opportunities is very limited, but the "arbs" are willing to take the time and effort to frequently earn those few pennies per share. (Read Arbitrage Squeezes Profit From Market Inefficiency.)

Proof
To determine if one position is equivalent to another, all you need to know is this simple equation:
S = C – P


This equation defines the relationship between stocks (S), calls (C) and puts (P). Being long 100 shares of stock is equivalent to owning one call option and selling one put option when those options are on the same underlying and the options have the same strike price and expiration date.

The equation can be rearranged to solve for C or P as follows:
C = S + P
P = C - S


This gives us two more equivalent positions:
1. A call option is equivalent to a long stock plus a long put (this is often called a married put).
2. A put option is equivalent to a long call plus a short stock .

From the last equation, if we change the signs of each attribute, we get:
-P = S – C, or a short put equals a covered call


As long as you are cash-secured, meaning you have enough cash in your account to buy the shares if you are assigned an exercise notice, there are two very practical reasons for selling a naked put:
1. Reduced Commissions
The naked put is a single trade. The covered call requires that you buy stock and sell a call. That's two trades.
• Exiting the Trade Prior to Expiration
Sometimes the spread turns into a quick winner when the stock rallies way above the strike price. It's often easy to close the position and take your profit easily when you sold the put. All you must do is buy that put at a very low price, such as 5 cents. With the covered call, buy the deep-in-the-money call options. Those usually have a very wide market and there is almost no chance to buy that call at a good price (and then quickly sell the stock). Thus, the strategic edge belongs to the put seller, not the covered call writer.
• Other Equivalent Positions
These positions are equivalent only when the options have the same strike price and expiration date.

Selling a put spread is equivalent to buying a call spread, so:
• Sell ZXQ Oct 50/60 Put Spread = Buy ZYQ Oct 50/60 Call Spread

Selling a call spread is equivalent to buying a put spread, so:
• Sell JJK Dec 15/20 Call Spread = Buy JJK Dec 15/20 Put Spread

Selling put spread is equivalent to a buying collar. so:
• Sell XYZ Nov 80/85 Put Spread = Buy 100 XYZ; Buy one Nov 80 put; Sell one Nov 85 call

To convert a call into a put, just sell stock (because C - S = P)
To convert a put into a call, just buy stock (because P + S = C)

The Bottom Line
There are other equivalent positions. In fact, by using the basic equation (S = C – P) you can find an equivalent for any position. From a practical perspective, the more complex the equivalent position, the less easily it can be traded. The idea behind understanding that some positions are equivalent to others is that it may help your trading become more efficient . As you gain experience, you will find it takes very little effort to recognize when an equivalent is beneficial. It just takes a little practice thinking in terms of equivalents.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 321

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 237

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 443

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 22

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 254

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 238

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Brand Engagement Network Welcomes Janine Grasso as New Leader

Updated Category News Views 154

Janine Grasso Takes the Helm at Brand Engagement Network Brand Engagement Network Inc. (NASDAQ: BNAI), a renowned player in the realm of AI-powered customer engagement, is excited to announce the appointment of Janine Grasso as the new Interim Chief Executive Officer. This transition marks a significant moment for the company as it continues to strengthen its leadership...

Continue Reading
Three Stocks Primed for Growth Amid Changing Inflation

Updated Category News Views 78

Understanding the Impact of Inflation on Stocks Inflation has a profound effect on the stock market, influencing investor psychology and pricing strategies across sectors. When inflation rises, many businesses experience greater earnings potential due to increased pricing power. However, when inflation begins to soften, some stocks may struggle while others adapt more...

Continue Reading
Datarails Unveils Fun Panda Mascot to Engage CFOs and Teams

Updated Category News Views 251

Datarails Introduces a Unique Panda Mascot Datarails has recently taken a creative approach in connecting with CFOs and their teams by introducing a vibrant panda mascot. This initiative showcases the company's commitment to making financial planning and analysis both engaging and relatable. Bringing a Playful Edge to Financial Challenges The newly launched panda mascot...

Continue Reading
LegalShield's Latest Index Insights Indicate Election Trends

Updated Category News Views 106

LegalShield's Consumer Stress Legal Index: A New Perspective ADA, Okla.—LegalShield's recent analysis of the Consumer Stress Legal Index (CSLI) seems to point towards a win for Democratic candidates in upcoming elections. Tracking around 150,000 calls every month from individuals seeking legal assistance, this index has accurately correlated with past presidential...

Continue Reading
Unveiling MySmile's Exciting Summer Sale: Shine Bright

Updated Category News Views 153

MySmile Oral Care Invites You to a Summer Smile Celebration Ready to transform your smile this summer? MySmile Oral Care is thrilled to announce a fantastic opportunity to enjoy 20% off sitewide during their limited-time Summer Smile Sale. With only hours left to take advantage of this deal, now is the perfect moment to elevate your oral care routine. Why You Should Join...

Continue Reading